Product has patent protection through 2044 - - Expected to be listed in the U.S. Food and Drug Administration's (FDA) Orange Book upon the product's approval - DEER PARK, Ill., Feb. 07, 2025 (GLOBE ...
London-based L&G is selling the US unit for USD2.3 billion to Japanese mutual life insurance firm Meiji Yasuda Life Insurance. The US insurance entity includes L&G's US protection and US pension risk ...
FENY's portfolio is heavily weighted towards Exxon Mobil and Chevron, with a low long-term EPS growth rate and neutral technical chart. Click to read why FENY is a Hold.